… insulin infusion is an effective form of intensive insulin therapy for people with type 1
diabetes as glycaemic control is slightly but significantly better than during optimised insulin …

… whether any improvement in glycaemic control or hypoglycaemia frequency using insulin
pump therapy was associated with the level of control achieved on insulin injections. …

… (CSII) allows administration of rapid-acting insulin analogues … of insulin administration, and
thereby better glycaemic control, … may result in improved glycaemic control and quality of life …

… perioperative glycaemic control have focused on postoperative and intensive care unit (ICU)
patients. This work has concentrated on goals of therapy, level of intensity of insulin infusion…

… agents, transfer to insulin is often necessary [1]. This usually results in … glycaemic control
but some patients remain inadequately controlled despite intensive treatment with large insulin …

… subcutaneous insulin infusion (CSII) differs from a multiple daily injection (MDI) regimen
based on neutral protamine hagedorn (NPH) as basal insulin with respect to glycaemic control …

… We conclude that good glycaemic control is maintained with continuous subcutaneous insulin
infusion over many years in approximately one third of people with Type 1 diabetes, whilst …

… effect of CSII on glycaemic control in a large cohort of adults with Type 1 diabetes and we
showed that the benefits of CSII therapy in improving glycaemic control and reducing mild to …

… glycaemic control on multiple daily insulin (MDI) injections and continuous subcutaneous
insulin infusion … variability is a major determinant of control and that the resultant HbA 1c on …

… in patients with Type 1 diabetes in good glycaemic control currently using CSII. … glycaemic
control with one glargine injection received glargine twice daily or extra injections of insulin …